Open Access
| Issue |
BIO Web Conf.
Volume 124, 2024
The 2nd International Conference on Food Science and Bio-medicine (ICFSB 2024)
|
|
|---|---|---|
| Article Number | 02006 | |
| Number of page(s) | 6 | |
| Section | Biomedical and Clinical Medical Research | |
| DOI | https://doi.org/10.1051/bioconf/202412402006 | |
| Published online | 23 August 2024 | |
- Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China 2022. Journal of the National Cancer Center, 2024;4(1):47–53. [CrossRef] [Google Scholar]
- Elliott B, Julia R. Targeted Therapy for Non-Small Cell Lung Cancer: First Line and Beyond. Hematology/Oncology Clinics of North America, 2023, 37(3):575–594. [CrossRef] [PubMed] [Google Scholar]
- Hopkins A M, Kichenadasse G, Mckinnon R A, et al. Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150. The British journal of cancer, 2022, 1:126. [Google Scholar]
- Mai T L, Huyen-Thu N, Xuan-Hung N, et al. Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer. Heliyon, 2023; 9(11):e22080. [CrossRef] [PubMed] [Google Scholar]
- Yan X, Qu F J, Zhou Y. Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases. Lung Cancer. 2023;184:107322. [CrossRef] [Google Scholar]
- Wang Y Z, Ding Y, Liu S, et al. Integrative splicing- quantitative-trait-locus analysis reveals risk loci for non-small-cell lung cancer. AJHG, 2023;110(9):1574–1589. [CrossRef] [Google Scholar]
- Ratnakumaran R, McDonald F. The Management of Oligometastases in Non-small Cell Lung Cancer-is Stereotactic Ablative Radiotherapy now Standard of Care. Clinical Oncology, 2022;34(11):753–760. [CrossRef] [Google Scholar]
- Yohann P, Merav R, Joseph S, et al. Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network. Clinical Lung Cancer, 2023; In press. [Google Scholar]
- Hu X H, Hu Q K, He Y, et al. Efficacy and safety of microwave ablation and its synergistic potential in the treatment of early-stage non-small cell lung cancer. Clinical Imaging, 2024;107:110070. [CrossRef] [PubMed] [Google Scholar]
- Huang Y, Bao T, Zhang T, et al. Machine Learning Study of SNPs in Noncoding Regions to Predict Nonsmall Cell Lung Cancer Susceptibility. Clinical Oncology, 2023;35(11):701–712. [CrossRef] [Google Scholar]
- Darren S, Bryan M D, Jessica S, et al. Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer: Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors. Thoracic Surgery Clinics, 2023; 33(2):189–196. [CrossRef] [PubMed] [Google Scholar]
- Sun W, Ma X Y, Wang Y X, et al. Light dose effect of photodynamic therapy on growth inhibition and apoptosis induction in non-small cell lung cancer: A study in nude mouse model. Photodiagnosis and Photodynamic Therapy, 2023; 44:103865. [CrossRef] [PubMed] [Google Scholar]
- Keith S, Chung Y K, Amanda L, et al. Assessment of treatment strategies for stage I non-small cell lung cancer in patients with comorbidities. Lung Cancer, 2022; 170: 34–40. [CrossRef] [PubMed] [Google Scholar]
- Katsutoshi S, Junichi S, Katsuhiro M, et al. Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced nonsmall-cell lung cancer. Cancer Genetics, 2022;266:1–6. [PubMed] [Google Scholar]
- Shinji N, Kaoru K, Kotone M. A Phase II Study of Ubenimex Combined With Pembrolizumab, Nab- Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q). Clinical Lung Cancer, 2024;25(1):85–90. [CrossRef] [PubMed] [Google Scholar]
- Anderson H, Hopwood P, Stephens RJ, et al. Gemcitabine plus best supportive care (BSC) vs. BSC in inoperable non-small celllung cancer —a randomized trial with quality of life as the primary outcome. Br JCancer, 2000;83(4):447–453. [CrossRef] [PubMed] [Google Scholar]
- Adam L, Yong Y, Laura E, et al. Treatment patterns for advanced non-small cell lung cancer in the US: A systematic review of observational studies. Cancer Treatment and Research Communications, 2022;33:100648 [CrossRef] [PubMed] [Google Scholar]
- Daria B, Javier S-G, Cornelia V, et al. T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. Inmmunity, 2023;56(1):143–161. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.